Shenzhen Shenyi Technology Co., Ltd.: Integrating AI with BCI to make brain-computer intelligence widely accessible to the general public

Recently, Shenzhen Shenyi Technology Co., Ltd. (hereinafter referred to as "Shenyi Technology") announced the completion of an angel round financing of over 10 million RMB. This round of financing was led by Lihe Venture Capital, with follow-on investment from Dongguan Biotech. The proceeds from this round will be mainly used for R&D of core brain-computer interface technologies, mass production of consumer-grade products and overseas market expansion, as well as clinical validation, registration and transformation of medical-grade products such as auxiliary diagnosis of depression and neuromodulation.

Founded in May 2025, Shenyi Technology focuses on the interdisciplinary innovation of AI + brain science, and develops brain function monitoring and intervention products based on artificial intelligence, non-invasive brain-computer interface and neuromodulation technologies targeting sleep disorders, depression and a variety of brain diseases.

▲ The cross-integration of AI and brain science is opening up new imaginative space for brain health management

01 "Serious Medical Treatment + Consumer Health": Two-line Synergistic Development Path

From the very beginning of its establishment, Shenyi Technology has established a two-line synergistic development path of "serious medical treatment + consumer health".

On the one hand, focusing on clinical demands such as sleep disorders and depression, the company continues to deploy auxiliary diagnosis based on EEG signals, as well as precise neuromodulation technologies including electrical stimulation, temporal interference stimulation and combined acoustoelectric stimulation, to build a technical moat.

On the other hand, wearable brain-computer interface products lower the threshold for brain function monitoring and intervention to enter daily life; relying on the rapid large-scale application of consumer-grade products, the company continues to accumulate large-scale real-world EEG and multi-modal data, which feeds back to algorithm training, personalized model optimization and product iteration, forming a data flywheel of "user growth — data accumulation — algorithm improvement — experience optimization".

02 From Brain Function Monitoring to "Monitoring + Intervention"

Medical end: Build a closed-loop diagnosis and treatment system of non-invasive and precise neuromodulation

▲ Precisely focus on neuromodulation

At the medical end, Shenyi Technology focuses on non-invasive, precise and deep brain neuromodulation, and builds a closed-loop diagnosis and treatment system from objective EEG assessment, personalized scheme decision-making to precise stimulation intervention for neuropsychiatric diseases such as sleep disorders and depression.

The company's first medical product is the closed-loop temporal interference electrical stimulation (TI) device, which not only realizes non-invasive precise stimulation of deep brain regions, but also dynamically optimizes the stimulation scheme through real-time feedback of multi-modal monitoring. According to the team, this product is also the first domestically developed closed-loop TI neuromodulation device for industrialization, which is different from most current technical routes dominated by unidirectional stimulation.

On this basis, Shenyi Technology also focuses on deploying multi-modal combined acoustoelectric stimulation technology, exploring a neuromodulation scheme with higher precision and more personalized capability under the coordination of focused ultrasound and electrical stimulation. According to the team, Shenyi Technology is also the first domestic team to systematically deploy the industrialization of multi-modal combined acoustoelectric stimulation, and is gradually building a precise neuromodulation technology platform covering different targets, different depths and different disease stages.

Consumer end: Let brain-computer interface enter daily life "unconsciously"

▲ Wearable brain-computer interface products integrate sleep and emotion management into daily life

At the consumer end, Shenyi Technology takes wearable brain-computer interface products as the entry point, combined with artificial intelligence algorithms to continuously analyze users' brain states related to sleep, emotion, etc., and further explores adaptive intervention based on individual brain states.

Focusing on the popular application of brain-computer interfaces, the company is continuously promoting hardware miniaturization, algorithm intellectualization and imperceptible use: by minimizing the volume of the EEG acquisition module to the extreme, reducing power consumption and wearing burden, and using AI to improve the capabilities of EEG signal processing, brain state recognition and personalized analysis in complex environments, so that brain-computer interfaces can gradually enter the scenarios of sleep, emotion and daily brain health management.

Focusing on the brain health management demands of healthy people and the diagnosis and treatment demands of patients with different degrees of brain diseases, Shenyi Technology will gradually establish a hierarchical product system covering daily brain health management, home intervention for mild population, in-hospital treatment and long-term out-of-hospital management for moderate and severe patients, promoting the capabilities of brain function monitoring and precise intervention to further extend from hospitals to families and daily life scenarios.

03 Joint Support from Market-oriented Capital and National Industrial Platforms

The lead investor in this round is Shenzhen Guangming Lihe Science City Seed Venture Capital Fund Partnership (Limited Partnership) under Lihe Venture Capital (hereinafter referred to as "Guangming Lihe Fund"). Lihe Venture Capital has long focused on early-stage scientific and technological innovation, adheres to the strategy of "investing in early-stage projects, small enterprises and hard-core technologies", and focuses on deploying technology enterprises with core technical barriers and industrialization potential. Guangming Lihe Fund was established with capital contributions from Shenzhen Angel Mother Fund, Guangming District Guidance Fund, Lihe Sci-Tech Innovation, etc.

Brain-computer interface is in the stage of accelerating evolution from cutting-edge technology verification to large-scale industrial implementation. Shenyi Technology has built a relatively complete technical system covering EEG acquisition, AI algorithms, precise neuromodulation and engineering, and through the two-line layout of "serious medical treatment + consumer health", it has formed a development path that takes into account short-term commercial verification and long-term construction of technical, clinical and regulatory barriers, with both technical depth, product implementation capability and industrialization potential.

—— Lihe Venture Capital

The follow-on investor in this round, Dongguan Biotech, focuses on cutting-edge fields such as biomedicine, medical devices and life health.

"Neuropsychiatric diseases such as depression have significant long-term and hierarchical diagnosis and treatment demands. Shenyi Technology focuses on objective EEG assessment and precise neuromodulation, and gradually builds a hierarchical product system covering patients with mild to moderate and severe depression, and promotes the extension of brain function monitoring and intervention capabilities from hospitals to families, which has clear clinical value and large-scale application space."

—— Dongguan Biotech

In addition to the investment institutions in this round, one of the founding shareholders of Shenyi Technology is Shenzhen National Research Institute of High Performance Medical Devices Co., Ltd., which is the operating entity of the National Innovation Center of High Performance Medical Devices. As the first national-level manufacturing innovation center in Shenzhen, this center is led and established by scientific research institutions, universities and leading medical device enterprises including Shenzhen Institute of Advanced Technology of Chinese Academy of Sciences, Mindray Medical, United Imaging Healthcare, Supera Medical and Harbin Institute of Technology, and has long promoted the R&D and industrial transformation of key common technologies for high-performance medical devices.

"Brain-computer interface is a cutting-edge direction of deep intersection of artificial intelligence, neuroscience and high-end medical devices. Shenyi Technology continues to promote productization around EEG, AI, precise neuromodulation and multi-modal diagnosis and treatment technologies, which is highly consistent with the direction of the innovation center to promote the engineering and industrialization of cutting-edge medical technologies."

—— National Innovation Center of High Performance Medical Devices

04 Make Brain-computer Interface a Technology Truly Accessible to the Public

Gu Xiangkun, founder of Shenyi Technology, said that the company will long promote the deep integration of artificial intelligence and brain-computer interface technologies, so that brain-computer interface is no longer just a cutting-edge technology in the laboratory or equipment that can only be used by a small number of patients and professional institutions, but gradually becomes a brain health technology that the public can access and use for a long time.

"AI is becoming an important force to promote the popularization of brain-computer interfaces. We hope to continuously promote hardware miniaturization, algorithm intellectualization and imperceptible use, continuously lower the threshold for using brain-computer interfaces, make the perception, understanding and intervention of brain functions more precise, natural and popular, so that brain-computer interfaces can truly move from laboratories to hospitals, and then from hospitals to families and the daily life of the public."

—— Gu Xiangkun, Founder of Shenyi Technology

05 Integration of Industry, University and Research to Accelerate Industrial Transformation

The core team of Shenyi Technology has a compound background in artificial intelligence, brain science, high-end medical devices, neuromodulation and software and hardware R&D, and its core members come from well-known enterprises such as United Imaging, Mindray, ByteDance and Tencent. Relying on the industry-university-research collaborative system composed of academicians of the Chinese Academy of Sciences, clinical experts from top tertiary hospitals and senior R&D personnel of brain-computer interfaces, the company has formed core capabilities covering algorithm, hardware, clinical transformation and engineering, and is jointly cooperating with industrial chains, scientific research and clinical institutions to accelerate the industrial implementation of serious medical products and consumer health businesses.

After completing this round of financing, Shenyi Technology will further increase investment in the core technology direction of two-way brain-computer interface, and promote product marketization and global brand building. In the future, Shenyi Technology will continue to expand the innovation boundary in the fields of neuromodulation and cognitive health, promote the transformation of brain science achievements from laboratories to clinical and public applications, and serve the demands of hundreds of millions of global users in brain health management such as neurological health and emotional rehabilitation with brain-computer interface technology.